BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 116549)

  • 1. Complement in tears from normal humans.
    Yamamoto GK; Allansmith MR
    Am J Ophthalmol; 1979 Oct; 88(4):758-63. PubMed ID: 116549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic complement in tears.
    Mondino BJ; Zaidman GW
    Ophthalmic Res; 1983; 15(4):208-11. PubMed ID: 6634056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo modulation of rat complement activities by infusion of anti-H antibodies.
    Veerhuis R; van Es LA; Daha MR
    Immunobiology; 1985 Sep; 170(3):133-45. PubMed ID: 2932382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate and classical pathway components of complement in the normal cornea.
    Mondino BJ; Ratajczak HV; Goldberg DB; Schanzlin DJ; Brown SI
    Arch Ophthalmol; 1980 Feb; 98(2):346-9. PubMed ID: 6766301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
    Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
    Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the alternative pathway of complement in the newborn infant.
    Adamkin D; Stitzel A; Urmson J; Farnett ML; Post E; Spitzer R
    J Pediatr; 1978 Oct; 93(4):604-8. PubMed ID: 702236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel assay for serum complement activity: C42 generation assay.
    Kobayashi E; Kitano E; Kitamura H
    Int Arch Allergy Immunol; 1999 Sep; 120(1):71-7. PubMed ID: 10529591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between the haemolytic activities of the human complement system and complement components.
    Takada A; Imamura Y; Takada Y
    Clin Exp Immunol; 1979 Feb; 35(2):324-8. PubMed ID: 436337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of complement activity and components C1, C4, C2, and C3 in complement response to bacterial challenge in malnourished rats.
    Sakamoto M; Ishii S; Nishioka K; Shimada K
    Infect Immun; 1981 May; 32(2):553-6. PubMed ID: 7251136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4, BF, C3 allele distribution and complement activity in healthy aged people and centenarians.
    Bellavia D; Fradà G; Di Franco P; Feo S; Franceschi C; Sansoni P; Brai M
    J Gerontol A Biol Sci Med Sci; 1999 Apr; 54(4):B150-3. PubMed ID: 10219002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo changes in human complement caused by silage.
    Olenchock SA; May JJ; Pratt DS; Lewis DM; Mull JC; Stallones L
    Environ Health Perspect; 1986 Apr; 66():91-6. PubMed ID: 3709488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
    Roncato M; Vial MC; Maillet F; Peltier A
    Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 16. The classical and alternate pathways of complement in oral contraceptive users.
    Delâge JM; Lehner-Netsch G; Brisson J
    Contraception; 1987 Dec; 36(6):627-32. PubMed ID: 3446439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement proteins and C3 anaphylatoxin in the tears of patients with conjunctivitis.
    Ballow M; Donshik PC; Mendelson L
    J Allergy Clin Immunol; 1985 Sep; 76(3):473-6. PubMed ID: 3875643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difference between serum and plasma complement activity in primary renal disease.
    Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
    Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breast.
    Vijayakumar T; Ankathil R; Remani P; Beevi VM; Vijayan KK; Panicker CK
    J Clin Immunol; 1987 Jul; 7(4):300-3. PubMed ID: 3611297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement consumption in acute disseminated intravascular coagulation without antecedent immunopathology.
    Branson HE; Wyatt LL; Schmer G
    Am J Clin Pathol; 1976 Dec; 66(6):967-75. PubMed ID: 136895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.